Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Love this board tonight. Good luck to All. $MINE
All questions will be answered but then variables will come about that will make all questions and answers pointless Again
Deals, Deals, Deals... None completed! Only online site and a building... More debt than revenue IMO... GL
Sitting here next to my buddy, he's been in SLTD before me and is a solid shareholder---UT
I live in UT also, and agree. Would never do business with Vivint.
I'll take that kind sir
If true; probably in regards to lost/stolen(fraudulent) shares. Could be good news
Huh, good luck with that
Witnessed my friend place order at the ask .1635 at EOD, it got filled at .1618. He tried to help it close green but looks like someone wouldn't sell at .1635
C'mon, there is a lot red. Who didn't buy on the run up? Some sold, and some rolled out for a loss to buy back in. The only ones not red are the ones who were long way before the run up and that is if they didn't cost average on the way up. Common sense.
Vivint's business model is garbage in my opinion, they trap people in payment plans for 20 years. SLTD has better business model, just not in Utah now
NREL Demonstrates 45.7% Efficiency for Concentrator Solar Cell
New design for ultra-efficient III-V multijunction cell pushes the limits of solar conversion. Now what?
Your post is right on! Thanks
@UTSmallBiz: [Salt Lake Tribune] Work begins on $1 billion solar plant in Nevada http://t.co/95LaU5uu37
Longs, and new investors: don't use stop loses on a day like tomorrow. If manipulated, stock will plummet quickly. GLTA! Don't give up your shares.
Gerald E. Commissiong, President & CEO of Amarantus stated, "I am extremely pleased with our current position, as we can now focus on the execution of our business plan to transform Amarantus into a commercial-stage company. We have made significant progress in the CLIA partnering selection process for LymPro and are now fine-tuning development with Becton Dickinson in preparation for its commercial launch later in 2014.
via npr: First Embryonic Stem Cells Cloned From A Man's Skin http://n.pr/1jKn7Z3
Thank you, I agree!
Great Post! Thank you.
Me too .086 Load up while you can
Thanks zoom; thought the same thing but it would be nice for CNN to broadcast AMBS story with LymPro
Just saw a Breaking News story on CNN that stated that a Dr. Federhoff had just discovered a blood test to identify Alzheimer's. How's that effect us AMBS?
I'll cheer a little today because I was able to increase my position at .58 Long $ELTP
Story from @nprnews: Just One Dose Of Many Common Medicines Can Kill A Child. That's why $ELTP will succeed. http://t.co/K73G5iA25Y
Please share how you came to that pps?
Keep $RFMD on watch Mon-Tue RFMD(R) to Showcase Portfolio of RF Solutions at 2014 Mobile World Congress
http://t.co/FUF3uTuXbe